2.1. Study Design and Participants
This hospital-based retrospective cohort study was approved by the Clinical Research Ethics Committee of Nagasaki University Hospital (approval no. 19111813) and was carried out according to the principles outlined in the Helsinki Declaration II.
In this study, we used the electronic patient medical records of patients who had been diagnosed with OSA and treated with MAOAs at Nagasaki University Hospital over a ten-year period from June 1, 2008, to May 31, 2018. All patients were diagnosed with OSA at the Respiratory Medicine Department and were found to be appropriate for treatment using MAOA after being referred to the Oral Surgery department for oral examination. An oral surgeon examined the oral condition (the presence of caries, periodontal disease, occlusion, temporomandibular joint movement, etc.) and checked a given patient’s suitability for MAOA treatment. Patients with severe periodontal disease or temporomandibular joint disorder and those with few (<12) remaining teeth were referred back to the Respiratory Medicine Department.
Patients considered suitable for MAOA treatment underwent maxillary and mandibular impressions and maxillomandibular registrations. The former were obtained using an alginate impression material. During the maxillomandibular registration, a patient’s mandible was guided so that the amount of forward movement of the mandible composed approximately 60–80% of maximum protrusion, and that of vertical opening was approximately 2–5 mm wider than a normal occlusion position. The patient was asked to maintain this position, and maxillomandibular registration was performed using a silicone registration material. For special occlusal conditions, such as open bite, mandibular retrusion (retrognathia), and deep overbite, the optimal position had been explored separately for each case.
Based on the information obtained from the Oral Surgery department, the OA was fabricated in a dental laboratory (Nagasaki University Hospital Dental Laboratory). The MAOA was basically constructed as a mobile device. The upper and lower appliance components were fabricated separately using the clear transparent polyethylenterephthalat-glycol (PETG) thermoplastic material (DURAN, Scheu Dental GmbH, Iserlohn, Germany) and attached using HDPE connectors (NK connector II, Morita Corp.), one on each side. The surface of the connection part was roughened and treated with dichloromethane, and the connector was attached with the self-curing resin (Unifast III Clear; Morita Corp). Its end was covered with a self-curing resin to ensure sufficient strength. A connector was positioned between a maxillary canine and a mandibular first molar. A single connector was used on each side; however, when instructed by an oral surgeon or after damage, reinforcement by fixing the prosthesis was sometimes performed using two connectors on each side.
The MAOA was fitted in the mouth by an oral surgeon and adjusted as necessary. Then, the patient was instructed on its proper use. After several weeks of use, symptom alleviation was checked, and if any problems arose, the relevant adjustments or repairs were made accordingly. Subsequently, patients were recommended to undergo regular check-ups (at least once every six months).
2.2. Variables
Information on variables presumed to be associated with MAOA survival was gathered from medical records.
The collected participant information covered sex, age at the time of placement, preoperative apnea-hypopnea index (AHI), and oxygen saturation (Sp02). As the information related to MAOA, the data reflected the initial situation, whether the device was repaired or newly produced, and the type of connection (single connector, two connectors, and fixed). Ultimately, relevant data on six variables were obtained.
2.3. Data Source
Data on the patients treated with MAOA were retrieved, and their medical records were followed up until December 11, 2019. Patients who visited only on the day of placement were excluded. Data were managed using Microsoft®️Excel for Mac version 16.78.3 (Microsoft Corp., Redmond, WA) and checked multiple times to avoid duplication and other errors.
The failures were classified into three patterns: A) destruction anywhere in MAOA, B) connector failure, and C) thermoplastic component breakage. All three of the above patterns were defined as three types of events, and the time until the occurrence of each event was considered the survival time. In the absence of any event, the survival time was censored at the date of the last observation. Survival time was determined using the date of the set as the baseline. Both repaired and remanufactured MAOAs were considered as devices distinct from the original one.
2.4. Statistical Analysis
Missing data were adjusted using multiple imputations. The survival time and rate were determined using the Kaplan–Meier survival analysis, and survival curves were constructed. Many participants were treated with multiple MAOAs, and it was speculated that personal factors such as the occlusal force might have affected the outcomes. Therefore, the shared frailty analysis involving a mixed-effects model that suggested the same frailty in participants was performed for each of the three failure types. Hazard ratios (HRs) and their respective 95% confidence intervals (CIs) were calculated for the variables presumably affecting each failure type. After evaluating the chosen variables with the stepwise method, HRs and CIs were re-estimated. The significance level was set at 5%.
R Studio version 2023.06.2 + 561 (Posit Software, PBC) was employed for the Kaplan–Meier survival and shared frailty analyses.